TCL Archive Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer August 27, 2010
TCL Archive NCI Director Says Research Budget Cuts Result in Untold “Missed Opportunities,” Provides List of Program Reductions. March 9, 2007
TCL Archive Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival April 25, 2014
TCL Archive In Brief: Cancer Program “Greatest Experiment And it Works,” ACS President tells Congress June 25, 1976